Chronic-Dose Safety and Efficacy Study of Albuterol Inhaler in Pediatric Asthmatics

- Asthma
- Completed

Study Title: A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics

Teva Identifier: ABS-AS-303

ClinicalTrials.gov Identifier: NCT02126839

Study Status: Completed

Trial Condition(s): Asthma

Interventions: Drug: Albuterol MDPI | Drug: Placebo | Drug: ProAir HFA inhaler

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child

Age Range: 4 Years to 11 Years

Trial Duration: 05/01/2014 - 02/01/2015

Phase: Phase 3

Study Type

Interventional